Hanmi Pharmaceutical co., Ltd. Company Profile

09:05 EDT 23rd March 2018 | BioPortfolio

Hanmi Pharmaceutical is a Korea-based pharmaceutical company. The Company invests over 20 percent of its sales in R&D and has over 20 programs consisting of the novel long acting biologics including weekly Insulin, weekly to monthly GLP-1, and their combination for diabetes and obesity (collectively referred as Quantum Project), the novel targeted anti-cancer drugs with improved tolerance and safety profile and fixed-dose combination drugs. For more detail about the company, visit

News Articles [266 Associated News Articles listed on BioPortfolio]

Lilly Halts Hanmi BTK Inhibitor Trial For RA, Mulls Other Indications

Hanmi Pharmaceutical shares fell sharply on the news Lilly has halted Phase II trials of the South  Korean firm’s BTK...  

Lilly axes trial of Hanmi's arthritis drug

Eli Lilly has opted to end a phase 2 rheumatoid arthritis (RA) trial of a drug it is developing with Korea’s Hanmi Pharmaceuticals, according to press reports. The Korea Biomedical Review cited a r...

Eli Lilly and Hanmi Shutter a Failed Phase II RA Trial

Eli Lilly and its Korean collaborative partner Hanmi stopped a Phase II trial on an experimental rheumatoid arthritis treatment following less-than-stellar interim results.

Lilly dumps Hanmi’s rheumatoid arthritis med

Eli Lilly and Hanmi signed an exclusive licensing and collaboration agreement to develop the Bruton’s tyrosine kinase (BTK) inhibitor, HM71224, for the treatment of various autoimmune and other dise...

Weak interim data prompt Lilly to drop mid-stage RA candidate

Indianapolis, USA-based Eli Lilly and South Korea’s Hanmi Pharmaceutical have shut down a Phase II…

Rolontis Leads Hanmi’s Global Ambitions As ADVANCE Phase III Endpoint Met

Rolontis, a novel, long-acting granulocyte colony-stimulating factor (G-CSF) licensed out to Spectrum Pharmaceuticals, has become Hanmi Pharmaceuticals' first drug developed...  

Lilly drops Hanmi-partnered arthritis drug

Concludes that its BTK inhibitor is likely to be clinically ineffective

Hanmi Pharmaceuticals Co Ltd 128940 Financial and Strategic SWOT Analysis Review [Report Updated: 13112017] Prices from USD $300

SummaryHanmi Pharmaceuticals Co Ltd Hanmi Pharma, a subsidiary of Hanmi Science Co Ltd is a developer of prescription drugs and over the counter drugs. The company's prescription drugs include osteopo...

PubMed Articles [416 Associated PubMed Articles listed on BioPortfolio]

Pharmaceutical care for patients of the third age in pharmacy organizations as a significant aspect of social gerontology.

There are questions in the article that study mutual relations of patients of elderly and senile age with pharmaceutical experts. It was revealed that pharmacy organizations are an important element i...

Pharmaceutical cocrystals as an opportunity to modify drug properties: From the idea to application. A review.

The properties of many drugs which have been available on the pharmaceutical market for a long time still need to be improved. Cocrystals are the solid state drug modification which can improve such p...

Total Health-related Costs Due to Absenteeism, Presenteeism, and Medical and Pharmaceutical Expenses in Japanese Employers.

This study aimed to examine a detailed breakdown of costs (absenteeism, presenteeism, and medical/pharmaceutical expenses), of the employees in four pharmaceutical companies in Japan.

Pharmaceutical Cocrystals: New Solid Phase Modification Approaches for the Formulation of APIs.

Cocrystals can be used as an alternative approach based on crystal engineering to enhance specific physicochemical and biopharmaceutical properties of active pharmaceutical ingredients (APIs) when the...

Editorial Special Supplement of the European Journal of Pharmaceutical Sciences on the occasion of the retirement of Professor Meindert Danhof as Professor of Pharmacology at Leiden University.

Clinical Trials [289 Associated Clinical Trials listed on BioPortfolio]

Pharmaceutical Care for Asthma Control Improvement (PHARMACI)-Study

The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for asthma patients.

Pharmaceutical Care for Diabetes Type 2 Patients: a Randomised Controlled Trial

The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for diabetes type 2 patients. Patients will be randomly allocated to th...

Improving Compliance Among Elderly Polypharmacy Users Through Community Pharmacy Based Pharmaceutical Care Program

The aim of the project is to evaluate effectiveness of a multidimensional pharmaceutical care plan in improving compliance among elderly polypharmacy users at community pharmacy settings. ...

Impact of Collaborative Pharmaceutical Care on Hospital Admission Drug Prescriptions for Patients 65 Years of Age and Older

The primary objective of this study is to evaluate the impact of the implementation of collaborative pharmaceutical care on drug support at admission for patients 65 years of age and older...

Individualized Pharmaceutical-care in Outpatients With Cancer Pain

The purpose of the study is to investigate the impact of pharmaceutical care on cancer pain treatment for opioid-tolerant outpatients

Companies [1017 Associated Companies listed on BioPortfolio]

Hanmi Pharmaceutical co., Ltd.

Hanmi Pharmaceutical is a Korea-based pharmaceutical company. The Company invests over 20 percent of its sales in R&D and has over 20 programs consisting of the novel long acting ...

Pharmaceutical Online

Pharmaceutical Online, the pharmaceutical manufacturing industry’s leading Web site. Our online community serves the product-sourcing and information-seeking needs of pharmaceutical professionals wo...

Cypress Pharmaceutical, Inc.

Cypress Pharmaceutical, Inc., founded in 1993, is a specialty pharmaceutical company that develops, markets and distributes generic prescription pharmaceutical products to leading...


Our Pharmaceutical products solution is focused to help manage the success of client’s business. We thrive on our innovative methodology to provide solution at an unmatched time to delivery and pr...


Bestpharmajobs does not charge any hidden fees, allowing pharmaceutical professionals to search pharmaceutical jobs, biotech jobs, medical sales, pharmaceutical sales jobs and be seen by potential pha...

More Information about "Hanmi Pharmaceutical co., Ltd." on BioPortfolio

We have published hundreds of Hanmi Pharmaceutical co., Ltd. news stories on BioPortfolio along with dozens of Hanmi Pharmaceutical co., Ltd. Clinical Trials and PubMed Articles about Hanmi Pharmaceutical co., Ltd. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Hanmi Pharmaceutical co., Ltd. Companies in our database. You can also find out about relevant Hanmi Pharmaceutical co., Ltd. Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record